- Home
- KRON vs RDZN Comparison
KRON vs RDZN Comparison
Compare KRON & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRON
- RDZN
- Stock Information
- Founded
- KRON 2017
- RDZN 2015
- Country
- KRON United States
- RDZN United States
- Employees
- KRON N/A
- RDZN N/A
- Industry
- KRON Medicinal Chemicals and Botanical Products
- RDZN Blank Checks
- Sector
- KRON Health Care
- RDZN Finance
- Exchange
- KRON Nasdaq
- RDZN Nasdaq
- Market Cap
- KRON 60.3M
- RDZN 54.8M
- IPO Year
- KRON 2020
- RDZN N/A
- Fundamental
- Price
- KRON $0.97
- RDZN $1.60
- Analyst Decision
- KRON Buy
- RDZN Strong Buy
- Analyst Count
- KRON 3
- RDZN 2
- Target Price
- KRON $1.63
- RDZN $5.00
- AVG Volume (30 Days)
- KRON 384.9K
- RDZN 682.5K
- Earning Date
- KRON 11-13-2024
- RDZN 02-10-2025
- Dividend Yield
- KRON N/A
- RDZN N/A
- EPS Growth
- KRON N/A
- RDZN N/A
- EPS
- KRON N/A
- RDZN N/A
- Revenue
- KRON $9,864,000.00
- RDZN $46,448,411.00
- Revenue This Year
- KRON $62.21
- RDZN $4.38
- Revenue Next Year
- KRON N/A
- RDZN $61.53
- P/E Ratio
- KRON N/A
- RDZN N/A
- Revenue Growth
- KRON 146.48
- RDZN 57.97
- 52 Week Low
- KRON $0.69
- RDZN $0.71
- 52 Week High
- KRON $1.60
- RDZN $7.17
- Technical
- Relative Strength Index (RSI)
- KRON 52.82
- RDZN 55.26
- Support Level
- KRON $0.92
- RDZN $1.18
- Resistance Level
- KRON $1.03
- RDZN $2.87
- Average True Range (ATR)
- KRON 0.06
- RDZN 0.43
- MACD
- KRON -0.00
- RDZN -0.01
- Stochastic Oscillator
- KRON 44.16
- RDZN 34.84
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.